You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 9, March 1, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Health Policy
 •Statistics and Research Methods
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Funding for Biomedical Research—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Dr Kupersmith highlights the significant investments the VA makes in biomedical research. The National Science Foundation source1 we used for our article indicates that for fiscal year 2002, federal obligations for biomedical research by the VA was approximately $250 million. Another report, also from the National Science Foundation,2 indicates that for fiscal year 2004, the preliminary federal research and development budget authority for veterans benefits and services was $820 million, similar to the figure Kupersmith cites. The discrepancy, which is likely due to accounting and definitional differences (all research and development vs that solely devoted to biomedical research), highlights the difficulty in assembling a complete and consistent picture of all public and private sources of research support. Availability of such a picture will allow all research sponsors to make more informed decisions regarding resource allocation. We intend to compile such data in the future and to make it . . . [Full Text of this Article]

Hamilton Moses III, MD
hm@alerion.us
The Alerion Institute
North Garden, Va

E. Ray Dorsey, MD, MBA
University of Rochester
Rochester, NY

David H. M. Matheson, JD, MBA
The Boston Consulting Group
Bethesda, Md

Samuel O. Thier, MD
Massachusetts General Hospital
Boston



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Financial Anatomy of Biomedical Research
, , , and
JAMA. ;294():1333-1342.
FULL TEXT  

Funding for Biomedical Research
and
JAMA. ;295():1000-1000.
FULL TEXT  

Funding for Biomedical Research
and
JAMA. ;295():999-1000.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.